» Authors » Lisa R Rogers

Lisa R Rogers

Explore the profile of Lisa R Rogers including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 27
Citations 377
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Akbari H, Bakas S, Sako C, Kazerooni A, Villanueva-Meyer J, Garcia J, et al.
Neuro Oncol . 2024 Dec; PMID: 39665363
Background: Glioblastoma is the most aggressive adult primary brain cancer, characterized by significant heterogeneity, posing challenges for patient management, treatment planning, and clinical trial stratification. Methods: We developed a highly...
2.
Ahluwalia M, Ozair A, Drappatz J, Ye X, Peng S, Lee M, et al.
Clin Cancer Res . 2024 Jun; 30(15):3167-3178. PMID: 38836759
Purpose: Patients with glioblastoma (GBM) have a dismal prognosis. Although the DNA alkylating agent temozolomide (TMZ) is the mainstay of chemotherapy, therapeutic resistance rapidly develops in patients. Base excision repair...
3.
Ahluwalia M, Rogers L, Chaudhary R, Newton H, Ozair A, Khosla A, et al.
Commun Med (Lond) . 2023 Sep; 3(1):120. PMID: 37684373
Background: Glioblastoma (GBM), the most lethal primary brain tumor, has limited treatment options upon recurrence after chemoradiation and bevacizumab. TRC105 (carotuximab), a chimeric anti-endoglin (CD105) antibody, inhibits angiogenesis and potentiates...
4.
Rogers L, Ostrom Q, Schroer J, Vengoechea J, Li L, Gerson S, et al.
Neurooncol Pract . 2020 Oct; 7(5):541-548. PMID: 33014395
Background: Metabolic syndrome is identified as a risk factor for the development of several systemic cancers, but its frequency among patients with glioblastoma and its association with clinical outcomes have...
5.
Rogers L, Oppelt P, Nayak L
Neuro Oncol . 2020 Feb; 22(6):892-893. PMID: 32047930
No abstract available.
6.
Neilson L, Rogers L, Sundararajan S
Stroke . 2018 Dec; 50(1):e9-e11. PMID: 30580735
No abstract available.
7.
Kang K, Grubb W, Sawlani K, Gibson M, Hoimes C, Rogers L, et al.
Am J Otolaryngol . 2018 Jun; 39(5):642-645. PMID: 29903623
Background: We present a case of myositis and possible overlapping neuromuscular junction disorder following treatment with nivolumab for recurrent/metastatic head and neck squamous cell carcinoma (HNSCC). Methods: We report a...
8.
Chien L, Gittleman H, Ostrom Q, Hung K, Sloan A, Hsieh Y, et al.
Front Public Health . 2016 Aug; 4:151. PMID: 27493936
Purpose: Reasons for worldwide variability in the burden of primary malignant brain and central nervous system (CNS) tumors remain unclear. This study compares the incidence and survival of malignant brain...
9.
Chien L, Ostrom Q, Gittleman H, Lin J, Sloan A, Barnett G, et al.
PLoS One . 2015 Jun; 10(6):e0129602. PMID: 26061037
Background: High grade gliomas are the most common type of malignant brain tumor, and despite their rarity, cause significant morbidity and mortality. This study aimed to compare the treatment patterns...
10.
Awan M, Liu S, Sahgal A, Das S, Chao S, Chang E, et al.
Expert Rev Anticancer Ther . 2015 Apr; 15(5):545-52. PMID: 25907706
Extra-CNS metastasis from glioblastoma (ECMGBM) is an emerging but little known clinical entity. We review pre-clinical and translational publications assessing the ability of GBM to spread locally and outside the...